Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer

Clinical Cancer Research

Volumn 6, Issue 12, 2000, Pages 4719-4724

  Smith, A M ^a   Justin, T ^a   Michaeli, D ^a   Watson, S A ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CHOLECYSTOKININ B RECEPTOR; EMULSIFYING AGENT; GASTRIMMUNE; GASTRIN; GASTRIN 17; GASTRIN 17 DIPHTHERIA TOXOID ANTIGEN; GASTRIN RECEPTOR; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ADVANCED CANCER; AGED; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; CHRONOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTRIN RELEASE; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN ABSCESS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CANCER VACCINES; CHOLECYSTOKININ; COLORECTAL NEOPLASMS; DIPHTHERIA TOXOID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTRINS; HUMANS; KINETICS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034485821     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gastrin
2. Expression of gastrin, gastrin/CCK-B and gastrin/CCK-C receptors in human colorectal carcinomas
3. Clinical significance of gastrin receptors in human colon cancers
4. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors
5. Gastrin receptor gene expression in several human carcinomas
6. Coexpression of gastrin and gastrin receptors (CCK-B and δ CCK-B) in gastrointestinal tumor cell lines
7. Incomplete processing of progastrin expressed by human colon cancer cells: Role of noncarboxyamidated gastrins
8. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors
9. Post-translational processing of gastrin in neoplastic human colonic tissues
10. Identification of progastrin derived peptides in colorectal carcinoma extracts
11. Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma
12. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma
13. Expression but incomplete maturation of progastrin in colorectal carcinomas
14. Gastrin enhanced tumor growth of a xenotransplantable human gastric carcinoma in nude mice
15. Gastrin stimulates growth of colon cancer
16. Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice
17. Gastrin: Growth enhancing effects on human gastric and colonic tumour cells
18. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines
19. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide
20. Processing and proliferative effects of human progastrin in transgenic mice
21. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation
22. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia
23. Chronic endogenous hypergastrinemia in humans: Evidence for a mitogenic effect on the colonic mucosa
24. Gastrin and colorectal cancer: A prospective study
25. Helicobacter pylori and omeprazole induced hypergastrinaemia promote colorectal carcinogenesis
26. The effect of the gastrin receptor antagonist proglumide on survival in gastric carcinoma
27. A pilot randomized control trial of proglumide (a gastrin receptor antagonist) in advanced colorectal cancer
28. Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth
29. Inhibition of gastrin-stimnlated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide
30. Gastrimmune inhibits the primary and secondary growth of 2 rat colon carcinomas
31. Active immunization against gastrin-17 with an N-terminal derived immunogen inhibits gastric and duodenal lesions in rats
32. Gastric acid suppression using anti-gastrin17 antibodies produced by a gastrin immunogen, gastrimmune, in an in vivo pig model
33. The effect of porcine anti-gastrin-17 antibodies on the pig gastrointestinal mucosa
34. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer
35. Antibodies targeting the amino terminal portion of the human CCKB/gastrin receptor inhibit the liver invasion of a human colonic tumor
36. Antibodies raised by Gastrimmune inhibit the spontaneous metastases of a human colorectal tumour cell line, AP5LV
37. Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC26) in Balb/c mice
38. Clinical significance of gastrin receptors in human colon cancers